期刊文献+

药物洗脱支架临床应用安全性的影响因素 被引量:1

Factors influencing clinical safety of drug-eluting stent
下载PDF
导出
摘要 目的:介绍药物洗脱支架在临床应用中的相关问题,从支架本身、涂层物质以及生物活性成分进行分析,探讨药物洗脱支架在临床应用中的安全性和有效性。方法:以"药物洗脱支架,金属裸支架,血管再狭窄"为中文关键词;以"Drug-eluting stent,Bare metal stent,Restenosis"为英文关键词,采用计算机检索1990-01/2008-10相关文章。纳入与药物洗脱支架与裸支架临床应用的安全性比较研究相关文章;排除重复研究或Meta分析类文章。以17篇文献为主重点探讨药物洗脱支架在临床应用中的安全性和有效性。结果:目前临床上所用的药物洗脱支架均存在值得进一步改进的可能,未来药物洗脱支架的发展方向是研发适合小血管、分叉部位的支架和扩展PCI适应证;寻求新的涂层、生物材料支架;研发支架药物的选择和洗脱技术,以及在维持DES作用、改善安全性的同时,寻找促进支架植入部位血管内膜愈合的方法。结论:改良支架平台及研发新型支架仍将是热点,注重远期疗效成为药物洗脱支架发展趋势。 OBJECTIVE:To introduce clinical application of drug-eluting stent,and explore the safety and efficacy by analyzing stent,eluting material,and bioactive components.METHODS:With key words "drug-eluting stent,bare metal stent,restenosis" in Chinese and English,a computer-based online search was performed for articles published between January 1990 and October 2008.Articles related to comparison of safety between drug-eluting stent and bare metal stent were included.Repetitive studies or Meta analysis were excluded.Finally,17 articles were selected,which discussed safety and efficacy of drug-eluting stent in clinical application.RESULTS:Currently used drug-eluting stent can be further improved to fit small vessels,furcation site and expanded PCI indications.Moreover,new coating and biomaterials,drug selection and eluting technique,methods to improve tunica intima healing at implant site are important.CONCLUSION:Modification of stent platform and development of novel stent become study hot spot.Long-term effect is significant for application of drug-eluting stent.
作者 李年秀
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第25期4729-4732,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献17

  • 1Langer R,Vacanti JP.Tissue engineering.Science.1993;260 (5110):920-926.
  • 2Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a strolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med.2002;346:1773.
  • 3Ardissino D,Cavallini C,Bramucci E,et al.Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries:a randomized trial.JAMA.2004;292:2727.
  • 4Popma JJ,Leon MB,Moses JW,et al.Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.Circulation.2004;110:3773.
  • 5Werner GS,Krack A,Schwarz G,et al.Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.J Am Coll Cardiol.2004;44:2301.
  • 6Pan M,de Lezo JS,Medina A,et al.Rapamycin-eluting stents for the treatment of bifurcated coronary lesions:a randomized comparison of a simple versus complex strategy.Am Heart J.2004;148:857.
  • 7Saia F,Lemos PA,Arampatzis CA,et al.Implantation for unselected in-stent restenosis:insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry.Heart.2004;90:1183.
  • 8Goy JJ,Stauffer JC,Siegenthaler M,et al.A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology The TAXi trial.J Am Coll Cardiol.2005;45:308.
  • 9谷新顺,张一达,傅向华.国产Firebird药物涂层支架与裸支架在急性心肌梗死患者中的对比研究[J].临床心血管病杂志,2007,23(9):704-705. 被引量:6
  • 10Nebeker JR,Virmani R,Bennett CL,et al.Hypersensitivity cases associatedwith drug-eluting coronary stents:a review ofavailable cases from the researchon adverse drug events and reports (RADAR) project.J Am Coll Cardio,2006,47(1):175-181.

二级参考文献22

  • 1罗林杰,董少红,麦爱欢,刘华东,陈科奇.药物洗脱支架在急性心肌梗死急诊冠脉介入治疗中的应用[J].中国实用内科杂志,2005,25(9):842-844. 被引量:6
  • 2LIU Hai-bo XU Bo GAO Run-lin YANG Yue-jin YAO Min QIN Xue-wen WU Yong-jian YUAN Jin-qing MA Wei-hua QIAO Shu-bin CHEN Ji-lin.Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry[J].Chinese Medical Journal,2006(7):609-611. 被引量:22
  • 3高润霖.药物洗脱支架研究现状及进展[J].中国实用内科杂志,2006,26(8):1121-1123. 被引量:19
  • 4Steven O, Andrew R. The development of rapamycin and its application to stent restenosis[J]. Circulation,2001,104: 852-855.
  • 5Morice MC, Serruys PW, Sousa JE, et al, A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascu-larization.The REVEL trial[J]. N Engl J Med, 2002, 346: 1773-1780.
  • 6Patrick W, Muzaffer D, Kengo T, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL trial[J].Circulation, 2002,106: 798-803.
  • 7Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stent [ J ]. Circulation,2001,104:2007-2011.
  • 8Sousa JE,Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stent, :part Ⅰ [J]. Circulation, 2003, 107 : 2274-2279.
  • 9Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stent. :part Ⅱ[J]. Circulation, 2003, 107 : 2383-2389.
  • 10Allen JM, Brett SL, Jonathan BG, et al. Stent thrombosis after successful sirolimus-eluting stent implantation [ J ]. Circulation, 2004,109 : 1930-1932.

共引文献13

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部